Aristides Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-100,555
Closed -$166K 250
2024
Q4
$166K Buy
+100,555
New +$166K 0.03% 253